Both in Biotechnology
Eikon Therapeutics vs Fennec Pharmaceuticals
Over the past year EIKN returned −64.1% and FENC returned +40.1%; their daily moves had a correlation of 0.27.
EIKN −64.1% FENC +40.1%Growth of $1, one year, split-adjusted
| Metric | EIKN | FENC |
|---|---|---|
| Price | $5.38 | $10.73 |
| Market cap | $291.4M | $376.3M |
| Today | −5.28% | +1.80% |
| 1 month | −28.6% | +1.0% |
| 6 months | −47.7% | +59.7% |
| Year to date | — | +39.4% |
| 1 year | — | +30.9% |
| Revenue growth (YoY) | — | +85.2% |
| Gross margin | — | 96.0% |
| Net margin | — | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.4× |
| Net cash | $531.2M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 100.3% | 55.2% |
| Short % of float | 20.4% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).